employer coverage glp-1 news october 2025 Perspectives from Employers on the Costs and Issues Associated with Covering Agonists for Weight Loss What You Need to Know

Here are some recent targets: Saket Kalia from Barclays set a target price of $22.0 on 01/05/2026 Sean Dodge from BMO Capital set a target price of $27.0 on 11/13/2025 Ryan MacDonald from Needham set a target price of $28.0 on 11/07/2025 Elizabeth Anderson from Evercore ISI Group set a target price of $28.0 on 11/07/2025 Vikram Kesavabhotla from Baird set a target price of $24.0 on 09/05/2025 Richard Close from Canaccord Genuity set a target price of $28.0 on 08/08/2025 Full Release SAN FRANCISCO, Jan

Rare: Pancreatitis, gallbladder issues, Ozempic face (facial fat loss)

Sometimes all at the same time

Stephanie B.